0001375852-17-000004.txt : 20170711 0001375852-17-000004.hdr.sgml : 20170711 20170711201256 ACCESSION NUMBER: 0001375852-17-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170710 FILED AS OF DATE: 20170711 DATE AS OF CHANGE: 20170711 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lamb Scott E CENTRAL INDEX KEY: 0001375852 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 17960805 MAIL ADDRESS: STREET 1: ICU MEDICAL, INC. STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-07-10 0 0000883984 ICU MEDICAL INC/DE ICUI 0001375852 Lamb Scott E 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Chief Financial Officer, Common Stock 2017-07-10 4 X 0 2998 46.53 A 9050 D Common Stock 2017-07-10 4 S 0 2698 170.0355 D 6352 D Common Stock 2017-07-10 4 S 0 300 171.0 D 6052 D Common Stock 2017-07-11 4 X 0 20774 46.53 A 26826 D Common Stock 2017-07-11 4 S 0 20774 170.0 D 6052 D Non-Qualified Stock Option (right to buy) 46.53 2017-07-10 4 X 0 2998 46.53 D 2022-02-01 Common Stock 0 20774 D Non-Qualified Stock Option (right to buy) 46.53 2017-07-11 4 X 0 20774 46.53 D 2022-02-01 Common Stock 0 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. All shares sold were sold at the exact price disclosed. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Transaction is the exercise of a derivative security; see Column 2. By: Paula Darbyshire, Attorney-in-fact For: Scott E. Lamb 2017-07-11